These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16799407)

  • 81. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
    Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
    Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Fatalities Due to Failure of Continuous Subcutaneous Insulin Infusion Devices: A Report of Six Cases.
    Ziegler A; Williams T; Yarid N; Schultz DL; Bundock EA
    J Forensic Sci; 2019 Jan; 64(1):275-280. PubMed ID: 29940703
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
    Potti LG; Haines ST
    J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Insulin pump therapy in childhood diabetes mellitus: guidelines for use.
    Tamborlane WV; Fredrickson LP; Ahern JH
    Treat Endocrinol; 2003; 2(1):11-21. PubMed ID: 15871551
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Continuous subcutaneous insulin infusion in patients with diabetes mellitus.
    Schiel R
    Ther Apher Dial; 2003 Apr; 7(2):232-7. PubMed ID: 12918949
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Morbidity and mortality of diabetic ketoacidosis with and without insulin pump care.
    Realsen J; Goettle H; Chase HP
    Diabetes Technol Ther; 2012 Dec; 14(12):1149-54. PubMed ID: 23009106
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Treatment of diabetes mellitus using an external insulin pump: the state of the art.
    Hanaire H; Lassmann-Vague V; Jeandidier N; Renard E; Tubiana-Rufi N; Vambergue A; Raccah D; Pinget M; Guerci B
    Diabetes Metab; 2008 Sep; 34(4 Pt 2):401-23. PubMed ID: 18951116
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Technical risks with subcutaneous insulin infusion.
    Guilhem I; Leguerrier AM; Lecordier F; Poirier JY; Maugendre D
    Diabetes Metab; 2006 Jun; 32(3):279-84. PubMed ID: 16799407
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.
    Pickup J; Keen H
    Diabetes Care; 2002 Mar; 25(3):593-8. PubMed ID: 11874953
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.